表紙:ポイントオブケア(POC)診断用ポリメラーゼ連鎖反応(PCR)市場
市場調査レポート
商品コード
986455

ポイントオブケア(POC)診断用ポリメラーゼ連鎖反応(PCR)市場

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics

出版日: | 発行: BCC Research | ページ情報: 英文 86 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
ポイントオブケア(POC)診断用ポリメラーゼ連鎖反応(PCR)市場
出版日: 2021年02月02日
発行: BCC Research
ページ情報: 英文 86 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のポイントオブケア(POC)診断用のポリメラーゼ連鎖反応(PCR)の市場規模は、2020年から2025年までの間に9.1%のCAGRで成長する見通しで、2020年の約33億米ドルから、2025年には50億米ドルに達すると予測されています。また、POC診断用PCRキットは12%、POC診断用PCR装置は3%のCAGRで、2020年から2025年の間に拡大すると予想されています。

当レポートは、世界のポイントオブケア(POC)診断用ポリメラーゼ連鎖反応(PCR)市場について調査しており、市場の概要、動向、規模や収益予測、規制の枠組み、課題、機器・キット・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

第2章 結論とハイライト

  • 価格/性能の動向
  • 機器の市場立ち上げ
  • 使用中の爆発
  • 分子の患者への推進
  • シングルテストからパネルへの進化

第3章 市場と技術の背景

  • イントロダクション
  • 進化
  • PCRの歴史
  • 1950~1960年代
  • 1970~1980年代
  • 1990年代~2017年
  • POC検査のための超高速PCR技術
  • POCでの従来のPCRの使用を制限するサーマルサイクリング
  • PCRサーマルサイクリングを管理するためのアプローチ
  • POCの新しいアプローチ
  • レーザーPCR:POCでの可能性の拡大
  • 結論
  • 核酸ベースのPOCアッセイに関連する技術的課題に取り組むための新しいアプローチ
  • 市場の決定要因
  • 感染症の高い発生率
  • COVID-19の有病率の増加
  • POC用PCRの使用
  • 感染症
  • 性感染症
  • その他の用途
  • POC用PCRテクノロジー
  • 検出
  • 等温増幅
  • マイクロフルイディクス
  • 規制の枠組み

第4章 COVID-19影響分析

  • COVID-19診断検査へのFDAの貢献
  • OTCおよび在宅テストソリューションの優先順位付け
  • 2020年5月以降のFDA関連のテストマイルストーンの要約
  • COVID-19影響分析に固有の競合情勢
  • COVID-19検査の開発
  • Meridian:新たな空気乾燥可能なRT-qPCRミックスの発表
  • FDA:MRSA細菌を特定するためのROCHEの新しい診断検査の許可
  • インフルエンザ/ SAR-CoV-2の組み合わせの診断検査

第5章 市場の内訳:機器別

第6章 市場の内訳:キット別

  • 感染症
  • マルチアナライトパネル
  • 単一分析物
  • 性感染症
  • バイオマーカー

第7章 市場の内訳:地域別

  • 北米
  • 米国
  • カナダ
  • 欧州
  • アジア太平洋
  • その他の地域
  • ラテンアメリカ

第8章 特許レビュー/新展開

第9章 テクノロジーの問題

  • 新興感染症とPOC用PCR
  • POC検査
  • POC用PCRの品質管理
  • 企業の戦略

第10章 業界構造

  • 公衆衛生
  • 臨床診断
  • 産業

第11章 デジタルPCRの追加情報

  • ケーススタディ:qPCRよりも絶対的な結果を提供するdPCR
  • ポーターのファイブフォースモデル
  • 液滴デジタルPCR
  • デジタルPCRの用途
  • クリニカル
  • 研究
  • フォレンジック
  • 業界構造

第12章 企業プロファイル

  • ABBOTT LABORATORIES
  • ADVANCED THERANOSTICS INC.
  • AQUILA DIAGNOSTICS SYSTEMS INC.
  • ATLAS GENETICS
  • BIO-RAD LABORATORIES INC.
  • CEPHEID
  • FLUXERGY
  • QIAGEN N.V.
  • ROCHE DIAGNOSTICS
  • VISBY MEDICAL INC.
図表

List of Tables

  • Summary Table : Global Market for PCR Technology-based POC Diagnostics, by Segment, Through 2025
  • Table 1 : Generations of PCR Technology
  • Table 2 : Commercial Systems for Near-Patient Testing
  • Table 3 : Global Prevalence of HIV Infections, 2000-2020
  • Table 4 : Global Mortality Cases Due to COVID-19, by Country, as of December 4, 2020
  • Table 5 : Global Estimates of New Cases of Curable STIs, 2016
  • Table 6 : Types of Detection for POC PCR Technologies
  • Table 7 : Types of Isothermic Amplification
  • Table 8 : Types of Microfluidics
  • Table 9 : Regulatory Frameworks Pertaining to PCR Technology
  • Table 10 : Competitive Landscape of PCR Technique for COVID-19
  • Table 11 : Global Market for PCR Equipment for POC Diagnostics, by Equipment Type, Through 2025
  • Table 12 : Global Market for PCR Kits for POC Diagnostics, by Kit Type, Through 2025
  • Table 13 : Number of New Cases of Sexually Transmitted Diseases in the United States, 1950-2017
  • Table 14 : Global Market for PCR for POC Diagnostics, by Region, Through 2025
  • Table 15 : North American Market for PCR for POC Diagnostics, by Country, Through 2025
  • Table 16 : COVID-19 Confirmed Cases and Deaths in the U.S., by State, as of December 11, 2020
  • Table 17 : Share of New Cancer Cases in Males Across the U.S., by Cancer Site, 2019
  • Table 18 : STI Cases Across Canada, by Age Group and Disease Type,* 2017
  • Table 19 : European Market for PCR for POC Diagnostics, by Country, Through 2025
  • Table 20 : COVID-19 Confirmed Cases in Europe, by Country, as of December 11, 2020
  • Table 21 : Asia-Pacific Market for PCR for POC Diagnostics, by Country, Through 2025
  • Table 22 : Rest of the World Market for PCR for POC Diagnostics, by Sub-Region, Through 2025
  • Table 23 : COVID-19 Confirmed Cases in Latin America, by Country, December 3, 2020
  • Table 24 : Middle East and North Africa HIV and AIDS Briefly, 2019
  • Table 25 : Patents in POC PCR, by Companies or Research Institutes
  • Table 26 : Threat of New Entrants Analysis, 2019 and 2025
  • Table 27 : Bargaining Power of Buyers Analysis, 2019 and 2025
  • Table 28 : Bargaining Power of Suppliers Analysis, 2019 and 2025
  • Table 29 : Threat of Substitutes Analysis, 2019 and 2025
  • Table 30 : Competitive Rivalry Between Existing Players, 2019 and 2025
  • Table 31 : Global Market for Digital PCR, by Type, Through 2025
  • Table 32 : Abbott Laboratories: Product Portfolio
  • Table 33 : Bio-Rad Laboratories: Product Portfolio
  • Table 34 : Cepheid: Product Portfolio
  • Table 35 : FluxErgy: Product Portfolio
  • Table 36 : FluxErgy: Recent Developments
  • Table 37 : Qiagen N.V.: Product Portfolio
  • Table 38 : Roche Diagnostics: Product Portfolio
  • Table 39 : Visby Medical Inc.: Product Portfolio
  • Table 40 : Visby Medical Inc.: Recent Developments

List of Figures

  • Summary Figure : Global Market for PCR Technology-based POC Diagnostics, by Segment, 2019-2025
  • Figure 1 : Shares of Global Prevalence of Malaria Cases, by Country, 2018
  • Figure 2 : Rise in Number of Cancer Patients, Projections and Trends, 2012 and 2030
  • Figure 3 : Incidences of Diagnosed Infectious Disease, by Country, 2019
  • Figure 4 : Global Market for PCR Equipment for POC Diagnostics, by Equipment Type, 2019-2025
  • Figure 5 : Global Market for PCR Kits for POC Diagnostics, by Kit Type, 2019-2025
  • Figure 6 : Funders for Malaria R&D Globally, 2018
  • Figure 7 : Donated Funds for R&D, by Diseases, 2018
  • Figure 8 : Number of Clinical Trial Studies Globally, 2010-2018
  • Figure 9 : Venture Investment in Infectious Disease Companies Across the U.S., 2006-2018
  • Figure 10 : Deaths Due to Infectious and Parasitic Diseases in Spain, by Age Group, 2018
  • Figure 11 : Trend in Geriatric Population in Germany, 2000-2030
  • Figure 12 : Allocation of Diagnosed Infectious Diseases in Selected Countries, by Gender, as of 2019
  • Figure 13 : Infectious Disease Treatments in China, by Disease Incidence, 2019
  • Figure 14 : Trends in Aging Population (Aged 65 Years and Above) in Japan, 2010-2040
  • Figure 15 : STD Incidence in China, by Disease, 2019
  • Figure 16 : Value Chain Analysis of PCR-based POC Market
  • Figure 17 : Global Market for Digital PCR, by Type, 2019-2025
目次
Product Code: BIO157B

Highlights:

The global market for polymerase chain reaction (PCR) for point-of-care (POC) diagnostics should grow from nearly $3.3 billion in 2020 to $5.0 billion by 2025, at a compound annual growth rate (CAGR) of 9.1% during the period of 2020-2025.

The global market for PCR kits for POC diagnostics should grow from $2.1 billion in 2020 to $3.7 billion by 2025, at a CAGR of 12.0% during the period of 2020-2025.

The global market for PCR equipment for POC diagnostics should grow from $1.2 billion in 2020 to over $1.3 billion by 2025, at a CAGR of 3.0% during the period of 2020-2025.

Report Scope:

The scope of this report is broad and covers the components available in the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market and potential end-users. Revenue forecasts from 2020 to 2025 are given for types of kits and equipment, with estimated value derived from the revenues of manufacturers.

The report also includes a discussion on the major players in each regional market. Further, it explains major drivers and regional dynamics of the global market. The report concludes with a look at the vendor landscape and includes detailed profiles of major vendors in the global PCR for POC diagnostics market.

This report will cover the variety of markets being served by these newly emerging diagnostic kits, the companies that produce them, and the types of end users who are embracing these kits. This study does not cover the existing kit market for molecular diagnostics, either through manual use or through a variety of automation platforms. These kits, which enable processing of samples for PCR without further operator intervention, by definition do not require much in the way of sample preparation or consumables other than what is used to generate results, so there will not be a discussion of that marketplace. However, the appropriate consumables necessary, as well as the cyclers that are paired with these kits, will be covered as a part of this report.

Report Includes:

  • 18 data tables and 23 additional tables
  • A comprehensive overview of the global market for polymerase chain reaction (PCR) for point-of-care (POC) diagnostics, along with future commercial potential for each key market segment
  • Analyses of the global market trends, with data from 2019 and 2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Estimation of the actual market size and revenue forecasts for the global PCR for POC diagnostics market and potential end-users for types of kits and equipment
  • Identification of the emerging market opportunities and future market potential of the PCR for POC diagnostics industry, technology trends and issues, market determinants, and regulatory frameworks pertaining to PCR technology
  • Competitive landscape specific to COVID-19 impact analysis, with emphasis on FDA's contribution to COVID-19 diagnostic testing and key developments within the segment
  • Patent review and new developments in POC PCR technologies, by companies or research institutes
  • Discussion of the vendor landscape and detailed profiles of major vendors in the global PCR for POC diagnostics market. Major players include Abbott Laboratories, Bio-Rad Laboratories Inc., Cepheid, Roche Diagnostics and Qiagen N.V.

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

  • Trends in Price/Performance
  • Market Ramp-Up in Equipment
  • Explosion in Uses
  • Pushing Molecular to the Patient
  • Evolving from Single-Test to Panels

Chapter 3 Market and Technology Background

  • Introduction
  • Evolution
  • History of PCR
  • 1950s-1960s
  • 1970s-1980s
  • 1990s-2017
  • Ultra-fast PCR Technologies for Point-of-Care Testing
  • Thermal Cycling Limits the Use of Conventional PCR at the POC
  • Approaches to Manage PCR Thermal Cycling
  • Novel Approaches for POC
  • Laser PCR: Expanding the Possibilities at the POC
  • Conclusions
  • New Approaches to Tackle Technical Challenges Correlated with Nucleic Acid-based POC Assays
  • Market Determinants
  • High Incidence of Infectious Diseases
  • Increasing Prevalence of COVID-19
  • Uses of POC PCR
  • Infectious Disease
  • Sexually Transmitted Disease
  • Other Uses
  • POC PCR Technology
  • Detection
  • Isothermic Amplification
  • Microfluidics
  • Regulatory Framework

Chapter 4 COVID-19 Impact Analysis

  • FDA's Contribution to COVID-19 Diagnostic Testing
  • Prioritizing of OTC and At-Home Testing Solutions
  • Synopsis of FDA-Associated Testing Milestones, Since May 2020
  • Competitive Landscape Specific to COVID-19 Impact Analysis
  • Developments in COVID-19 Testing
  • Meridian Introduces Novel Air-Dryable RT-qPCR Mix
  • FDA Allows Roche's Novel Diagnostic Test for Identifying MRSA Bacteria
  • Diagnostic Test for Combined Flu/SAR-CoV-2

Chapter 5 POC PCR Market Breakdown by Equipment

Chapter 6 POC PCR Market Breakdown by Kits

  • Infectious Diseases
  • Multi-analyte Panels
  • Single Analyte
  • Sexually Transmitted Diseases
  • Biomarkers

Chapter 7 POC PCR Market Breakdown by Region

  • North America
  • United States
  • Canada
  • Europe
  • Asia-Pacific
  • Rest of the World
  • Latin America

Chapter 8 Patent Review/New Developments

Chapter 9 Technology Issues

  • Emerging Diseases and POC PCR
  • Point-of-Care Testing: Not Just at The Patient Bedside
  • Quality Control of POC PCR
  • Company Strategies

Chapter 10 Industry Structure

  • Public Health
  • Clinical Diagnostics
  • Industrial

Chapter 11 Digital PCR Additional Information

  • Case Study: dPCR Offers More Absolute Results Over qPCR
  • Porter's Five Forces Model
  • Threat of New Entrants
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Competitive Rivalry Between Existing Players
  • Droplet Digital PCR
  • Applications of Digital PCR
  • Clinical
  • Research
  • Forensics
  • Industry Structure

Chapter 12 Company Profiles

  • ABBOTT LABORATORIES
  • ADVANCED THERANOSTICS INC.
  • AQUILA DIAGNOSTICS SYSTEMS INC.
  • ATLAS GENETICS
  • BIO-RAD LABORATORIES INC.
  • CEPHEID
  • FLUXERGY
  • QIAGEN N.V.
  • ROCHE DIAGNOSTICS
  • VISBY MEDICAL INC.